EthiZone-Taz is a “fixed-dose combination” medication. It contains Ceftriaxone (an antibiotic) and Tazobactam (a beta-lactamase inhibitor). This combination is designed to fight “resistant” bacteria. Some bacteria produce an enzyme called beta-lactamase that destroys the antibiotic before it can work. Tazobactam acts as a shield, neutralizing those enzymes so that the Ceftriaxone can successfully attack and kill the bacteria.

The 562.5mg dose is a specific formulation used to treat complex infections where resistance is suspected. It is commonly used for complicated respiratory infections, severe UTI, and peritonitis. This combination is a powerful tool in modern medicine for treating hospital-acquired infections. It is administered via injection and requires professional medical oversight to monitor for any allergic reactions. Patients must inform their doctor if they have a history of penicillin allergies, as there can be cross-sensitivity between penicillin and cephalosporins.